Pin Oak Investment Advisors’s AstraZeneca AZN Stock Holding History
Bought
Maintained
Sold
Other funds holding AZN
IA
VCM
VAM
Pin Oak Investment Advisors's AZN Position: Q1 2026 in Review
Pin Oak Investment Advisors opened a new position in AstraZeneca (AZN) in Q1 2026: 103 shares worth $20K. The stake represents 0.01% of the portfolio and ranks #308 among its holdings. This is a return to the name: Pin Oak Investment Advisors previously reported a position in AZN as recently as Q3 2025.
Pin Oak Investment Advisors first reported a position in AZN in Q4 2017 and has held it in 19 quarters since. The position peaked at $30K in Q1 2024. 1,377 funds tracked by Wall St. Rank hold AZN as of Q1 2026.
- Pin Oak Investment Advisors held 103 shares of AstraZeneca worth $20K as of Q1 2026.
- AstraZeneca was a new Pin Oak Investment Advisors position in Q1 2026.
- AstraZeneca made up 0.01% of Pin Oak Investment Advisors's portfolio in Q1 2026, its #308 holding.
- Pin Oak Investment Advisors first reported a position in AstraZeneca in Q4 2017 and has held it in 19 quarters since.
- Pin Oak Investment Advisors's AstraZeneca position peaked at $30K in Q1 2024.
- 1,377 funds tracked by Wall St. Rank held AstraZeneca as of Q1 2026.
Based on Pin Oak Investment Advisors's 13F filing for Q1 2026, filed 15 May 2026.